Our mission is to improve peoples health and quality of life by offering caregivers and healthcare professionals therapeutic solutions according to the highest standards of quality and safety, in the name of innovation.
Alfasigma is one of the leading Italian pharmaceutical companies, operating in over 100 countries worldwide with approximately 4,000 employees dedicated to research, development, production, and distribution.
With more than 70 years of history, the Company has a longstanding track record in developing innovative therapeutic indications to meet the new needs of patients while renewing and consolidating its existing products.
Alfasigma has a strong focus in gastroenterology and worldwide has products also in vascular, metabolic areas and in nutraceuticals and medical foods. As part of its strategy to expand its specialty care portfolio, Alfasigma strengthened its international presence with targeted acquisitions in US and Europe in 2023.
Alfasigma’s historical headquarters are located in Bologna, with another office in Milan. It has production sites in Italy, in Pomezia (RM), Alanno (PE), Sermoneta (LT) and Trezzano Rosa (MI), and abroad in Tortosa, Spain and in Shreveport (Louisiana) in the United States. Its R&D laboratories are in Pomezia and in the Parco Scientifico Tecnologico Kilometro Rosso in Bergamo.
Read here our social media netiquette: https://it.alfasigma.com/informative-privacy/netiquettesocialnetwork/
